Transforming Clinical Trials with Real-World Evidence | BCG
Adding new experimental arms to randomised clinical trials: Impact on error rates - Babak Choodari-Oskooei, Daniel J Bratton, Melissa R Gannon, Angela M Meade, Matthew R Sydes, Mahesh KB Parmar, 2020
Introduction and Malaysia's Experience in Phase 1 Clinical Trials
G.500 - PHS Human Subjects and Clinical Trials Information
EFPIA Positionn Paper - Innovation in Clinical Trial Design White Paper final
An overview of platform trials with a checklist for clinical readers - Journal of Clinical Epidemiology
The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine
The next generation of evidence-based medicine | Nature Medicine
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis | The BMJ
Clinical trial design and how it can be used to improve the patient experience - PMLiVE
Randomised trials at the level of the individual - The Lancet Global Health
Phase II trials - memoinOncology
Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials | British Journal of Cancer
Do mindful people have lower blood pressure? - Quora
Botanical drug clinical trial: common issues and future options